C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/47 (2006.01) A61K 31/505 (2006.01) A61K 31/535 (2006.01) C07D 215/36 (2006.01) C07D 215/38 (2006.01) C07D 401/14 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2108014
2108014 9219614 PCTABS00017 Compounds of formula (I) and the pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, m, X and Q are as defined below, and novel intermediates used in the synthesis of such compounds. The compounds of formula (I) are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.
Limited Pfizer
Smart & Biggar
LandOfFree
4-aryl-3-(heteroarylureido)quinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aryl-3-(heteroarylureido)quinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aryl-3-(heteroarylureido)quinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1746173